Smart J-aggregate of cyanine photosensitizer with the ability to target tumor and enhance photodynamic therapy efficacy

Miao Li,Wen Sun,Ruisong Tian,Jianfang Cao,Ye Tian,Bhaskar Gurram,Jiangli Fan,Xiaojun Peng

DOI: https://doi.org/10.1016/j.biomaterials.2020.120532

IF: 14

2021-02-01

Biomaterials

Abstract:<p>Photodynamic therapy (PDT) has been demonstrated to be effective for cancer treatment. Design of photosensitizers (PS) featuring tumor targeting, long excitation wavelengths, and high singlet oxygen quantum yields (Φ(¹O₂)) is the crucial point of highly efficient PDT. However, it is especially difficult to integrate above features into one photosensitizer. Herein, we put forwards a PS J-aggregation method, simultaneously endowing PS with the ability of tumor targeting, the red-shift of spectra, and the increase of Φ(¹O₂). Cyanine PS 4-((E)-3-((E)-5-iodo-1,3,3-trimethylindolin -2-ylidene)prop-1-en-1-yl)-1-methylquinolin-1-ium iodide (<strong>IDMQ</strong>) is firstly designed and synthesized by us. <strong>IDMQ</strong> can form smart response-type J-aggregates under the control of negatively charge in microenvironments. In blood, <strong>IDMQ</strong> J-aggregates target tumor via "enhanced permeability and retention (EPR)" effect. Then the intracellular <strong>IDMQ</strong> J-aggregates assembled by RNA facilitate the red shift of absorption peak with deeper penetration, and compared to free state <strong>IDMQ</strong>, improve the Φ(¹O₂), resulting in the bathochromic shift of optimal PDT wavelength from 630 (free state <strong>IDMQ</strong>) to 700 nm (<strong>IDMQ</strong> J-aggregates). This intelligent J-aggregation method establishes a promising way for endowing photosensitizer with the ability of tumor-targeting and the synchronous improvement of PDT efficacy and further boosts the development of PDT.</p>

engineering, biomedical,materials science, biomaterials